Cantor Fitzgerald came out and expressed concerns around the Magnificent Seven group, saying the stocks are “vulnerable,” suggesting that there could be a shift in fund flows towards different ...

Cantor Fitzgerald High Income Fd earns an Average Process Pillar rating. The predominant contributor to the rating is the parent firm's five-year risk-adjusted success ratio of 81%. The measure ...

In a report released yesterday, Troy Jensen from Cantor Fitzgerald reiterated a Buy rating on Proto Labs (PRLB – Research Report), with a price target of $50.00. The company’s shares closed ...

Tuesday, Cantor Fitzgerald reaffirmed its Overweight rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) with a consistent price target of $480.00. According to InvestingPro data ...

Cantor Fitzgerald raised the firm’s price target on Protolabs (PRLB) to $50 from $40 and keeps an Overweight rating on the shares. Protolabs reported better-than-expected revenue and adjusted ...

Shares of AMTM stock opened at $22.13 on Friday. Amentum has a one year low of $18.38 and a one year high of $34.50. The company has a quick ratio of 1.57, a current ratio of 1.59 and a debt-to ...

Cantor Fitzgerald analyst M. Prisco now forecasts that the semiconductor company will post earnings of $6.40 per share for the year, down from their previous forecast of $6.55.

On Monday, Cantor Fitzgerald reiterated its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC), currently trading at $13.39, after an incident involving a potential news leak. According to ...

Get your questions answered by the editors at Trains and learn more about the railroading industry.

On Wednesday, February 5 th, Cantor Fitzgerald significantly increased the price target on the stock to $8.00 from $3.50 and maintained an “Overweight” rating. BigBear.ai soared after securing ...